Dermacyd Femina (Lactic Acid) - Photo Dermatological Evaluation of the Irritation and Sensitivity Potential.

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

To prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Femina.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sanofi
• Treatments: Dermatologic Agents

Criteria

Inclusion Criteria:

• Phototype Skin II and III;

• Integral skin test in the region;

Exclusion Criteria:

• Lactation or gestation;

• Use of Anti-inflammatory and/or immuno-suppression drugs 15 days before the selection;

• Diseases which can cause immunity decrease, such as HIV, diabetes;

• Use of drug photosensitizer;

• History of sensitivity or irritation for topic products;

• Active cutaneous disease which can change the study results;

• History or photodermatosis active;

• Family or personal antecedent of cutaneous photoinduced neoplasias;

• Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium;

• Intense solar exposure in the study area;

• Use of new drugs or cosmetics during the study;

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.